evolcSign inStart free
Menu

Adipopharma

Develops peptide therapeutics targeting insulin resistance and type 2 diabetes for patients with metabolic disease

Strasbourg, FranceFounded 2017adipopharma.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-13

Recent signals

What changed at Adipopharma in the last 6 months, newest first. Each line links to its public source.

  • 2 Nov 2026 Publishing · Started publishing: 5 blog or news posts in 30 days adipopharma.com
  • 2 Nov 2026 In the news · AdipoPharma advances PATAS into a Phase 1b clinical trial adipopharma.com
  • 2 Nov 2026 In the news · AdipoPharma begins Phase 1b dosing of PATAS adipopharma.com

Get signals like these for the companies you sell to →

About Adipopharma

AdipoPharma is a French biotech developing PATAS, a stapled peptide designed to target adipose tissue and address insulin resistance, type 2 diabetes and associated conditions. The company reports preclinical results and says PATAS entered clinical trials in 2025.

The company was created to commercialize research by founder Vincent Marion and his team on adipocytes and metabolic disease. It was founded in 2017 and is headquartered in Strasbourg, France.

Product: PATAS, a stapled peptide therapeutic candidate targeting adipose tissue to treat insulin resistance, type 2 diabetes and associated conditions.

Jobs at Adipopharma

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Adocia

    Develops therapies for diabetes and obesity for patients with chronic metabolic diseases
    Lyon, FranceBiotech & pharmaFounded 2006

  • Adragos Pharma

    Contract development and manufacturing for pharma and biotech clients in Europe, Japan and North America
    FranceBiotech & pharma32 open jobs

  • Advesya

    Clinical-stage biotech developing IL-1RAP-targeted CAR T-cell and ADC treatments for cancer and autoimmune diseases
    Paris, FranceBiotech & pharmaFounded 2020
    New on Evolc

  • Aelis Farma

    Develops CB1-targeting drug candidates for people with cannabis-related disorders and cognitive deficits
    Pessac, FranceBiotech & pharmaFounded 2013

  • Aenitis Technologies

    Acoustic levitation cell-handling devices and single-use consumables for cell and gene therapy bioprocessing
    Mitry-Mory, FranceBiotech & pharmaFounded 2014
    New on Evolc

  • Aequil Science

    Programmable biophysical signals for companies developing health, agriculture, environmental and technology products
    Saint-Genis-Pouilly, FranceBiotech & pharmaFounded 2024
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.